search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Cover story - advertising feature


essential to protect patients and preserve capacity.


Multiplex POC PCR testing has the potential


to bring laboratory-quality diagnostics closer to the patient, helping to enable rapid treatment decisions, effective isolation and improved patient flow.12


When delivered through intuitive,


connected platforms, these solutions support frontline teams without compromising quality or governance.


References 1. Superflu 2025: Reality or exaggeration? BMJ2026; 392 doi: https://doi.org/10.1136/bmj. s13


2. GOV.UK. (2026) Norovirus cases continue to remain stable but high. https://www.gov.uk/ government/news/ukhsa-weekly-winter- surveillance-bulletin. Accessed 23 February 2026.


3. IFS. (2024). The past and future of UK health


spending. https://ifs.org.uk/publications/past- and-future-uk-health-spending


4. CEPA. (2024) A ‘broken’ NHS, £22.6 billion and a big reform agenda. https://www.cepa.co.uk/ images/uploads/documents/CEPA_NHSreport_ Nov24.pdf. Accessed 23 February 2026.


5. NHS England. (2024) Combined adult and paediatric acute respiratory infection (ARI) hubs. https://www.england.nhs.uk/long- read/combined-adult-and-paediatric-acute- respiratory-infection-ari-hubs/ Accessed 23 February 2026.


6. GOV.UK. (2026). COVID-19. https://ukhsa- dashboard.data.gov.uk/respiratory-viruses/ covid-19. Accessed 23 February 2026.


7. Garg I. et al. (2022). COVID-19 and Influenza Coinfection Outcomes among Hospitalized Patients in the United States: A Propensity Matched Analysis of National Inpatient Sample. Vaccines. 10(12):2159. doi:10.3390/ vaccines10122159


8. Flu in numbers: NHS faces one of the worst winters ever, officials warn, amid concerns over mutated strain. BMJ2025; 391 doi: https:// doi.org/10.1136/bmj.r2391


9. Bartsch S, et al. (2016) Global economic burden of norovirus gastroenteritis. PLoS ONE. 11(4):e0151219.


10. Moss JWE, et al. (2020) Quantifying the direct secondary health care cost of seasonal influenza in England.BMC Public Health. 20(1):1464. doi:10.1186/s12889-020-09553-0


11. Garcia-Rodriguez, J et al. (2025). Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications. Microorganisms 13, 63. 12. Fistera D, et al. (2023). Point-of-care PCR


Cepheid UK Ltd, Oakley Court, Frederick Pl, Loudwater, High Wycombe HP11 1JU


Tel: 01628 564000 April 2026 I www.clinicalservicesjournal.com 9


testing of SARS-CoV-2 in the emergency department: Influence on workflow and efficiency. PLoS One. 18(8):e0288906. doi: 10.1371/journal.pone.0288906. PMID: 37535577; PMCID: PMC10399729.


13. Pöhlmann J, et al. (2025) Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost- Consequence Analysis for High-Risk Patients in Primary Care in Germany. Advances in Therapy. 42(5):2385-2402. doi: 10.1007/s12325-025-03156- 0. Epub 2025 Mar 22. PMID: 40120029; PMCID: PMC12006223


14. Dewar S, et al. (2019). Point-of-care testing by healthcare workers for detection of meticillin- resistantStaphylococcus aureus,Clostridioides difficile, and norovirus. Journal of Hospital Infection. 103(4):447-453.


Footnotes IVD. In Vitro Diagnostic Medical Device. May not be available in all countries. *For positive Norovirus results with early assay termination. Otherwise, full runtime is 90 minutes.


ckybe - stock.adobe.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84